NAV
$56.37
AUM
$72.1M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.96
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +5.31% | +10.56% | +19.62% | +35.59% | +10.11% | +4.02% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Co | 12.67% |
| 2 | IQMM | ProShares GENIUS Money Market ETF | 11.81% |
| 3 | JNJ | Johnson & Johnson | 7.86% |
| 4 | ABBV | AbbVie Inc | 5.57% |
| 5 | UNH | UnitedHealth Group Inc | 4.98% |
| 6 | MRK | Merck & Co Inc | 4.26% |
| 7 | TMO | Thermo Fisher Scientific Inc | 2.68% |
| 8 | AMGN | Amgen Inc | 2.62% |
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Inception Date: 2007-01-30